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Abstract
Mass spectrometry-based metabolomic analysis depends upon
the identification of spectral peaks by their mass and retention time.
Statistical analysis that follows the identification currently relies on one
main peak of each compound. However, a compound present in
the sample typically produces several spectral peaks due to its isotopic
properties and the ionization process of the mass spectrometer device.
In this work, we investigate the extent to which these additional peaks
can be used to increase the statistical strength of differential analysis.
We present a Bayesian approach for integrating data of multiple
detected peaks that come from one compound. We demonstrate
the approach through a simulated experiment and validate it on ultra
performance liquid chromatography-mass spectrometry (UPLC-MS)
experiments for metabolomics and lipidomics. Peaks that are likely to
be associated with one compound can be clustered by the similarity of
their chromatographic shape. Changes of concentration between sample
groups can be inferred more accurately when multiple peaks are
available.
When the sample-size is limited, the proposed multi-peak
approach improves the accuracy at inferring covariate effects. An R
implementation, data and the supplementary material are available
at http://research.ics.aalto.fi/mi/software/peakANOVA/.
1 Introduction
The study of changes in the levels of metabolites and lipids has become
essential for the comprehensive understanding of human health [18]. Mass
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spectrometry (MS) techniques have become the standard method for
characterizing the human metabolome [17] and lipidome [14]. The technique
generates a spectrum of peaks in the plane defined by the retention time and
the mass-to-charge ratio of an observed particle. Each peak in this plane is
either generated by a particle arising from one of the compounds present in
the sample, or is an artifact of the measurement without association to any of
the compounds. The association between the peaks and compounds is
unknown a priori. The produced peak data are noisy: First, sample
preparation introduces sources of uncertainty that propagate to
the analysis [5]. Second, the accuracy of the device is limited [22] and it
produces biases. Third, peak identification, annotation and pre-processing
steps produce additional layers of uncertainty [19]. The effect of errors at all
these levels is exacerbated by the “small n, large p” problem: experiments
cover a very limited number of samples, n, while the set of compounds
measured, p, is potentially large.
However, there also is strong informative structure in the data: First, each
compound may generate multiple adduct peaks [10] (Figure 1) and isotope
peaks [12, 3] (Figure 2), whose positions and shapes provide information about
the identity of the compound. Second, the concentrations of different
compounds generated by or participating in similar biological processes may
be highly correlated [20]. An increasing number of machine learning
algorithms are being developed for inferring such structure either from raw
spectral data [8] or from processed intensity data [2]. The inference of
covariate effects—the differences between sample groups determined by
external covariates such as an intervention—is in the core of the comparative
analysis of spectral profiles [11]. In this work, we propose an unsupervised
approach for inferring covariate effects from the data more accurately through
the modeling of multiple peaks arising from a single compound (Figure 3).
The existence of additional peaks in the spectrum is usually seen as
a problem and only the main peak of each identified compound is used for
further analysis. All peaks are a result of the ionisation process where
a charged particle is attached to or detached from a compound. Each
compound-ion pair produces a distinct adduct or deduct peak. Random
variation in the ionisation process leads to inconsistencies between batches of
samples, perceived as variation in the ratio of intensities of the peaks
associated with one compound. This is a major source of error for all existing
analysis approaches regardless of the choice of the peak used for the analysis.
On the other hand, the distribution of the intensities of isotope peaks is by
nature well preserved across both samples and compounds. Moreover,
the natural isotopic distribution of a compound is known and can be used to
make peak annotation more precise. In this way, isotope peaks provide reliable
additional information about the differences in compound concentrations
between sample groups.
We propose a probabilistic approach for extending statistical analysis to all
available peaks and show that the additional peaks can provide a real benefit
to the inference of covariate effects in an experiment. The approach is used to
cluster the peaks that are likely to arise from a single compound together and to
infer the changes in concentrations of the compounds more accurately based on
all these peaks. By this approach, we are addressing the problem of inadequate
sample-size by introducing additional data describing the compounds behind
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Figure 1: A schematic of the positions of typical adduct peaks [10]
in the RT-m/z plane for two lipids, the ceramide Cer(d18:1/17:0) and
the sphingomyelin SM(d18:1/22:0). An adduct peak is formed by an ion
attaching to the compound. At the finer detail, each peak in the figure consists
of multiple isotope peaks few atomic units apart, as shown for Cer(d18:1/17:0)
in Figure 2. Even though the distinct isotope peaks are not visible to the eye
here, they are clearly separable by the mass spectrometer. In the figure, adduct
types and compounds are marked by colors and characters, respectively.
the noisy measurements.
To solve the problem we introduce the following assumptions about
the generative process of the data within a Bayesian model: First, samples
carry between-group differences in their compound concentrations and
the differences arise from responses to external covariates. Second, multiple
observed spectral peaks follow an identical generative process and their heights
are a noisy reflection of the true concentration level of the compound. Third,
shapes of the peaks from one compound are generated through an identical
process following the properties of the measurement device, and thus these
shapes are highly similar.
The approach presented in this paper consists of two stages of
computational inference: (1) peaks that share a compound as their generative
source are clustered together, and (2) the responses to external covariates are
inferred on these groups of peaks.
The clustering part of the approach is based on a nonparametric Bayesian
Dirichlet process model [16]. To improve the performance of the clustering
model, we have redefined the prior distributions of the model to have a better
match to the distribution of the peak shape similarity observations than in
the original proposition.
The model for inferring the responses to covariates operates on clusters
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Figure 2: Natural isotopic distribution of the mass of a typical lipid,
the ceramide Cer(d18:1/17:0). The presence of atomic isotopes leads to
the appearance of multiple mass spectral peaks from the compound. The isotope
peaks have distinct mass-to-charge ratios at the same retention time (Figure 1).
inferred in the first part. A Bayesian multi-way model [11] is suitable for this
task. This model itself could be used for clustering summarized mass spectral
intensity data, but in this work, we demonstrate that the clustering can be
done more accurately based upon the similarity of chromatographic peak
shapes.
2 Methods
This section describing the models consists of two parts: clustering of spectral
peaks and inference of covariate effects. To maintain the mathematical rigor in
the section, we use the terms “samples,” “variables” and “clusters,” to refer to
the experimental runs of the mass spectrometer, the peaks in the mass
spectrometry data, and the yet unknown compounds in the experimental runs,
respectively. In the equations, we denote samples, variables and clusters by
the indices i, j and k, respectively:
i =1, . . . , N (samples, i.e., experimental runs),
j =1, . . . , P (variables, i.e., peaks),
k =1, . . . ,K (clusters, i.e., compounds),
(1)
where N , P and K are their total numbers.
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Figure 3: Schematic of spectral peaks in two samples. Peaks on the left arise
from one compound while peaks on the right arise from another compound.
The heights of the peaks from one compound have a constant relative difference
between the two samples (solid and dashed lines), which can be used to improve
the accuracy of analysis. Distinct peaks from one compound (marked by colors)
have distinct mass-to-charge ratios but they share the same retention time.
2.1 Clusters of peaks based on the similarity
Following earlier work [16], we measure the similarity between the shapes of
two peaks by their correlation computed over a window of retention time after
a standard peak alignment [15] across the samples. Truncating negative values
to zero, this leads to a distinct similarity matrix Qi·· ∈ [0, 1]P×P for each
sample i. In the notation, the operator “·” indicates that the entire dimension
of the array is included, not only the single item j. Because a peak is not
necessarily observed in every sample, there may be missing values in
the matrices. Therefore, we construct an additional mask R ∈ {0, 1}N×P×P
with binary values rijj′ indicating whether peaks j and j
′ have any overlap in
sample i.
2.1.1 Model
We assume that the peaks are generated through a Dirichlet process [6]: there
is an unknown number of clusters and an unknown and variable number of
peaks that arise from each of the clusters. Peaks are assumed to have a one-
out-of-many association: each peak is associated with only one of the unknown
clusters. With these basic assumptions, we can infer the P -by-K clustering
matrix V from the data Q. To make the following equations more compact, we
use an additional variable εjj′ = vj·vTj′· ∈ {0, 1}, which is an inner product
of the cluster indicator vectors of the peaks j and j′, to denote whether the two
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peaks come from the same or different clusters (1 or 0, respectively).
We set a spike-and-slab prior [13] for the peak shape similarity to model
the inherent sparse structure of the data. The similarity between any pair of
observed peaks (j, j′) is assumed to follow a beta distribution, but the shape of
the distribution is assumed to depend on whether the pair comes from
the same cluster or from different clusters (shape parameters (ain, bin)
or (aout, bout), when εjj′ = 1 or 0, respectively). Also the probability of
a missing similarity value is assumed to depend on the cluster assignment of
the pair (pin0 or p
out
0 , when εjj′ = 1 or 0, respectively). The distributional
assumptions are summarized as
p (qijj′ , rijj′ = 1|εjj′ = 1) =
(
1− pin0
)
Beta (qijj′ |ain, bin) (2)
p (qijj′ , rijj′ = 0|εjj′ = 1) = pin0 δ (rijj′) (3)
for a pair of peaks in the same cluster and
p (qijj′ , rijj′ = 1|εjj′ = 0) =
(
1− pout0
)
Beta (qijj′ |aout, bout) (4)
p (qijj′ , rijj′ = 0|εjj′ = 0) = pout0 δ (rijj′) (5)
for a pair of peaks in different clusters. The Dirac delta function δ, which is
a point mass at zero, constitutes the “spike” of the two-component mixture
distribution.
Combining Equations from 2 to 5, the likelihood of the entire peak shape
data becomes a product over all peak pairs and samples:
L (Q,R|V) =
N∏
i=1
P−1∏
j=1
P∏
j′=j+1
p (qijj′ , rijj′ |εjj′ = 1)εjj′
× p (qijj′ , rijj′ |εijj′ = 0)1−εjj′ .
(6)
We introduce a Dirichlet process prior for assigning peaks into clusters. In
the non-parametric model, the probability of assigning peak j to an existing
cluster k,
p (vjk = 1|Q,R,V·,−k) ∝ skL (Q,R|V−j,·, vjk = 1) , (7)
is proportional to the likelihood of the peak given the cluster, weighted by
the current size of the cluster, sk = v
T
−j,kv−j,k. In the notation, matrices V·,−k
and V−j,· correspond to the matrix V with the row k and the column j omitted,
respectively. Alternatively, with probability
p (vj,K+1 = 1|Q,R,V) ∝ αDPL (Q,R|V−j,·, vj,K+1 = 1) , (8)
the process may create a new cluster with the index K + 1 and only the peak j
inside. Now the likelihood term is weighted by the Dirichlet process
concentration parameter αDP.
2.1.2 Inference
We infer the posterior distribution of the clustering via Gibbs sampling, which
results in a set of S samples of the clustering V(s), s = 1, . . . , S, from the true
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posterior distribution p (V|Q,R). Further analysis can operate on the entire
posterior distribution of the clustering through integration or on a point estimate
of the distribution.
We follow earlier work [4] and acquire a point estimate of the posterior
distribution of the clustering through finding the least-squares clustering:
the posterior sample s whose adjacency matrix V(s)V(s)T has the smallest
squared deviation from the posterior pairwise probabilities Π of the peaks.
The index of the least-squares clustering thus is
sLS = arg min
s∈{1,...,S}
P−1∑
j=1
P∑
j′=j+1
(
v
(s)
j· v
(s)T
j′· − pijj′
)2
, (9)
where the posterior pairwise probabilities
Π̂ =
1
S
S∑
s=1
V(s)V(s)T (10)
are estimated as the average adjacency matrix over the posterior samples.
2.2 Covariate effects based on peak heights
Having inferred the grouping of similar peaks into clusters that each correspond
to a compound, we infer the differences in concentrations between sample groups
for each cluster given the peak height data X ∈ RP×N and the clustering V.
Again, there may be missing values in the data.
2.2.1 Model
After a peak-specific centering based on the control group, the observed peak
heights for each sample i are assumed to be normally distributed with a cluster-
specific mean xlat·i :
x·i|V,xlat,σ2 ∼ N
(
Vxlat·i ,Λ
)
, (11)
where the diagonal matrix Λ contains the peak-specific variance
parameters σ2 ∈ RP+. The cluster-specific means are assumed to be normally
distributed with a sample group-specific prior α,
xlat·i |α, ai ∼ N (α·ai , I) , (12)
where ai ∈ {1, . . . , La} is an indicator of group membership (covariate level)
for sample i and I is a K-by-K identity matrix. The corresponding covariate
effects are arranged into an K-by-La matrix α and the effects are assumed to
be independent and normally distributed,
α·l ∼
{
δ (α·l) , l = 1
N (0, I) , l = 2, . . . , La, (13)
except for the first level, l = 1, which is defined as the baseline level and thus
is fixed to zero.
The model is not limited to one covariate. For an arbitrary number of
covariates, the cluster-specific means (Equation 12) can be expressed as a sum of
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individual covariate effects and the interaction effects of two or more covariates.
This generalization can be written as
xlat·i |E,C ∼ N (Ec·i, I) , (14)
where C is an L-by-N binary matrix, whose column i indicates the known
levels of all the covariates and all their resulting interaction levels for sample i.
The matrix E has dimensions K-by-L and its row k contains the effects ek· of
the respective covariates and their interactions for cluster k. Similarly,
Equation 13 can then be generalized as
e·l ∼ δ (e·l) , (15)
when any of the covariates is at the base level, and
e·l ∼ N (0, I) (16)
otherwise.
The peak-specific variance parameter
σ2j ∼ Scale-Inv-χ2
(
n0, σ
2
0
)
(17)
follows a scaled inverse-χ2 distribution with n0 prior samples and a scale σ
2
0 .
2.2.2 Inference and analysis
We infer the covariate effects via Gibbs sampling. Now the clustering
matrix V has been learned earlier, and is thus taken as known in the model.
The posterior distributions of the covariate effects α are descriptive of
the differences between the sample groups and thus interesting from
the analysis point of view. To assess the significance of the difference between
a sample group c > 1 and the control group c = 1 for a cluster k, we can study
the posterior probability of the effect αkc being greater or smaller than zero.
3 Results
We demonstrate the performance of the proposed method through three
experiments: a simulated data experiment, a spike-in benchmark experiment
with known changes in concentrations, and a gene silencing experiment with
measurements of the lipidome of cancer cells.
Evaluation of the performance on real data sets is not a trivial task, as there
is no ground truth available: neither the identity of the peaks nor the true effect
sizes are known. Thus, we also use spike-in data, where the true covariate effects
are known, although only a small number of the peaks are annotated.
For the simulated and benchmark experiments, we can compute the mean
squared error (MSE) between inferred and true covariate effects and use that
as an evaluation metric. As a result of the log-transformation of the intensity
data, we are quantifying relative changes between sample groups, independent
of the average height of each peak. In the model, we thus assume that
the change is preserved across the peaks of one compound, in relative terms.
The significance of the difference in the MSE of the proposed approach and
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the comparison method is tested by a paired one-sided t-test. The false
discovery rate is controlled by the Benjamini-Hochberg step-up procedure [1]
at level 0.01. Additionally for the simulated experiment, we can study
the inference of the statistical significance of effects, as the true distribution of
the data is known.
To assess the sensitivity of the approaches to noise in natural lipidomic data
lacking a ground truth, we use two types of indirect evaluation: First, we study
the consistency of the inferred covariate effects given a prior assumption about
their similarity. Second, we examine the robustness of the inferred covariate
effects to noise. Finally, we demonstrate differences between the multi-peak and
single-peak approaches through examples of qualitative analysis of annotated
peak clusters.
We compare the performance of the following approaches and refer to them
as Models 1, 2 and 3:
1. the multi-peak approach using both peak shape and height information,
as proposed in this work (nonparametric clustering of peaks by their shape
similarity, inference of covariate effects on the clusters based on the height
of the peaks),
2. the multi-peak approach using peak height information
only [11] (clustering of peaks and inference of covariate effects based on
the height of the peaks only),
3. the typical single-peak approach (inference of covariate effects by
the height of the strongest annotated peak only).
For the studied real data sets, we discover that peak height information alone is
not enough for clustering the peaks into individual compounds due to the high
level of noise and strong correlations between compounds. Thus, for real data
we compare Model 1 to Model 3 and highlight the benefit gained by using peak
shape information.
3.1 Simulated data
3.1.1 Introduction
We start by investigating the performance of the proposed approach on
synthetic data, where the true covariate effects are known. We focus on
a usual task in exploratory analysis of biological data: the detection of
significant non-zero covariate effects. We measure the performance by
the accuracy at this task—the ratio of true positive and true negative
significant differences among all effects. We use the 95 % posterior quantiles to
determine the significance. Additionally, we compute the MSE to the true
effects and follow earlier work [21] at studying the performance of the two
clustering models by computing the normalized information distance (NID) to
the true clustering.
The approaches are tested across a set of potential experimental settings to
study how the observation of additional peaks and samples affect
the performance. Simulated data are generated by assuming the latent
structure of Model 1. The following data parameters are varied on a grid:
sample-size N = 2 × {3, 7, 15} and peak-specific noise σ2 = {1, 5}.
9
Additionally, the number of peaks per cluster are varied between 3, 7 and 15.
Covariate effects α·2 = [2,−1, 0.5, 0, 0, 0, 0] are generated for each data set.
The experiment is repeated 100 times with independent data sets.
3.1.2 Result
On normal level of noise (σ2 = 1), the multi-peak approaches (Models 1 and 2)
always perform better at detecting significant covariate effects than
the single-peak approach (Model 3; Figure 4a) and only with enough samples
the performance of Model 2 becomes comparable to Model 1. The inferred
clustering of Model 1 is perfect while the clustering performance of Model 2 is
heavily dependent on the number of samples available (Figure 4c).
On high level of noise (σ2 = 5), only Model 1 works (Figure 4b). The reason
for the failure of Model 2 is the imperfectly inferred clustering (Figure 4d).
The good performance of Model 1 comes from the clustering step, which is
robust to noise in the peak heights. The peak shape similarity yields strong
evidence for inferring the clusters already from a single sample.
The MSE between the inferred and true covariate effects for Model 1 is
smaller compared to Model 3 in all 24 setups of the experimental grid.
The difference is statistically significant in 22 setups and in all setups at
the high level of noise.
The performance of the multi-peak approaches clearly improves, when more
peaks from a cluster are present in the data (Figure 5). This is pronounced
at a high level of noise, when the observation of a single peak is unreliable for
inferring the covariate effects. In a similar way as in averaging over samples,
the model is able to overcome peak-specific noise also by averaging over multiple
peaks.
3.2 Benchmark data with known changes
in concentrations
3.2.1 Introduction
In the first demonstration on real UPLC-MS data [7], we show that Model 1 can
infer the artificial perturbations in a spike-in experiment more accurately than
the single-peak approach. The recently-published benchmark data set of apple
samples includes a set of annotated spike-in compounds with increases of 20, 40
or 100 % in concentrations.
We start with the raw spectral data 1 in order to acquire the shapes of
the peaks in addition to their heights. The mass spectra are pre-processed
using MZmine 2 [15] (Section 3 in Supplementary material).
We evaluate the approaches by the MSE between inferred and true covariate
effects. If the cluster contains multiple annotated peaks, the effect of each
annotated peak is evaluated separately for the single-peak approach. Clusters
with no annotated peaks are considered to have a 0 % true effect and the effect
of the single-peak approach is inferred based on the strongest peak of the cluster.
1The raw spike-in data [7] is available at http://cri.fmach.eu/Research/Computational-
Biology/Biostatistics-and-Data-Management/download/data/Spiked-Apple-Data
[Accessed 11.06.2013].
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1Figure 4: The use of data from multiple peaks and the peak shape information
increase the accuracy at detecting significant covariate effects on simulated data.
Accuracy of Models 1, 2 and 3 for simulated data is shown as a function of
the sample-size in two settings: normal and high level of noise (left: σ2 = 1, and
right: σ2 = 5, respectively). Top (a-b): Accuracy at inferring the significance
of the generated covariate effects. Bottom (c-d): Normalized information
distance (NID) between the inferred and the true clustering. An entirely random
and an exactly correct clustering correspond to a NID of 1 and 0, respectively.
3.2.2 Result
All clusters with annotated peaks are specific to one compound. In the negative
ion mode, all peaks from one compound are clustered together. In the positive
ion mode, peaks from two compounds are distributed to two and four clusters.
Model 1 has a lower error than Model 3 at all magnitudes of the true effect with
the strongest improvement occurring at the small magnitudes (Table 1).
Based on the performance of the single-peak approach, it is evident that
the signal-to-noise ratio is low even in this type of a spike-in data set with
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Figure 5: The performance of Model 1 improves when more peaks per compound
are available in the simulated data. Curves A, B and C show the accuracy
as a function of sample-size for simulated data with 15, 7 and 3 peaks per
compound, respectively.
Table 1: Model 1 yields a more accurate quantification of the covariate
effects for the spike-in compounds as well as for the unchanged non-annotated
compounds in the benchmark experiment. Root mean squared error (RMSE)
between the inferred and true covariate effects is smaller for Model 1 than for
the single-peak approach (Single) at all magnitudes of the true effect (rows),
in both the positive (a) and negative (b) ion modes. Statistical significance of
the differences between errors is evaluated using the one-sided paired t-test
on the null-hypothesis of equal MSEs. Significant differences at confidence
levels 95 % and 99 % are highlighted by symbols ”*“ and ”**,“ respectively.
True covariate effect RMSE Corrected p-value
Single Model 1 of the difference
a) Positive ion mode
0 % 0.37 0.27 < 2.2× 10−16∗∗
20 % 0.38 0.19 7.3× 10−4∗∗
40 % 0.41 0.27 1.2× 10−2∗
100 % 0.95 0.82 6.6× 10−2
b) Negative ion mode
0 % 0.38 0.28 < 2.2× 10−16∗∗
20 % 0.40 0.18 9.2× 10−4∗∗
40 % 0.52 0.27 3.2× 10−4∗∗
100 % 0.77 0.60 5.0× 10−2
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a highly controlled experimental setup. Model 1 can significantly improve
accuracy at the quantification of covariate effects hidden under the noise,
particularly when true effects are weak.
3.3 Lipidomic data from a gene silencing study
3.3.1 Introduction
In the second demonstration on real UPLC-MS data [9], we show that Model 1
can infer more consistent covariate effects even though the actual true effects
are unknown. The data come from a recent experiment to study the effects
of gene silencing treatments on lipidomic profiles and growth of breast cancer
tissue.
Driven by the lack of ground truth about the covariate effects, we evaluate
the inferred effects indirectly in two ways: by quantifying the consistency of
the effects within a lipid family and by quantifying the robustness of
the magnitudes of the inferred effects across the lipidome in presence of
additional noise. Additionally, we investigate the stability of the inferred
clustering on the data and qualitatively analyze differences between
the covariate effects of single peaks and the effects inferred on clusters of peaks
by Model 1.
The data include 32 lipidomic profiles of breast cancer cells from
the ZR-75-1 cell line. We infer the effects of seven distinct silencing
interventions on metabolism- regulating genes (Section 4 in Supplementary
material) at two time points. The raw spectra are pre-processed with
MZmine 2 as described in the original publication [9], in addition to which
the shape similarity of the peaks is computed.
3.3.2 Consistency of effect signs
In the first task, we quantify the consistency as the accuracy at predicting
the covariate effect of a test lipid given the model on the covariate effects of
other lipids of the same family. We examine signs of effects instead of absolute
effects because even within a family of lipids, the changes have a high variance
and thus cannot be reliably predicted without imposing additional information
about the biological system.
We predict the signs of the covariate effects for test lipids in a three-fold
cross-validation setting with 100 randomizations. The examined lipids include
the annotated members from the three most abundant families of lipids that
have two or more peaks identified with the clustering model (Section 4 in
Supplementary material). Further, we study the influence of noise to
the consistency by adding independent normally distributed noise to the peak
intensity observations.
Model 1 proves more consistent than Model 3 at all noise levels (Figure 6).
When no noise is added and also at moderate levels of noise, both approaches
perform clearly better than expected by random chance. When noise is added,
Model 3 suffers more and its performance falls to the random level more rapidly.
If our assumption about the general similarity of lipids within a family is true, we
can conclude that Model 1 yields infers the covariate effects more consistently.
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Figure 6: Model 1 yields a better accuracy at the prediction of signs of covariate
effects for previously unseen lipids in the lipidomic gene-silencing data set.
The difference to Model 3 becomes pronounced when simulated noise is added to
the data. The prediction is based on the inferred covariate effects of compounds
from the same lipid family and is done in a cross-validation setting. In the task,
the effects of the seven gene-silencing treatments are predicted on the three
most abundant families of lipids in two time points. Points σ = 0 and σ > 0
on the x-axis show the prediction accuracy (y-axis) for the original data and
the data with added noise, respectively.
3.3.3 Robustness of effect magnitudes
To evaluate the inferred effects at the scale of the entire observed lipidome, we
examine the consistency of inferred covariate effects between the original and
noise-added data sets. This experiment simulates the situation where the true
effects are known (effects from the original data set), but the data based on
which the effects are inferred are noisy (the added-noise data set). To measure
the consistency, we compute the Spearman correlation between the covariate
effects inferred from the original and the added-noise data sets for all clusters
with two or more peaks.
Model 1 proves more consistent than Model 3 at all noise levels (Figure 7).
The confidence intervals from the 100 randomizations do not overlap at all at
moderate levels of noise. This gives indication that for a typical biological data
set, there is clear benefit from the analysis of multiple peaks, leading to reduced
variance of the result.
3.3.4 Stability
As the proposed approach is sensitive to the inferred clustering of the data, we
analyze the stability of the inferred clustering on biological data, using
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Figure 7: The covariate effects inferred by Model 1 are more robust to noise
compared to Model 3. At moderate levels of noise, which is the regime of
many biological experiments, the confidence intervals over 100 randomizations
do not overlap at all. The robustness is quantified as the Spearman
correlation (y-axis) between the effects inferred from the noisy and noise-free
versions of the lipidomic gene silencing data set as a function of the level of
noise (x-axis).
the lipidomic gene silencing data as a case. We test the influence of
the concentration parameter αDP in the Dirichlet process clustering model.
The clustering result for the lipidomic gene silencing data turns out to be very
robust to changes in the magnitude of the concentration parameter (Figure 2
in Supplementary material). As expected, the number of clusters increases as
the preset value of the concentration parameter increases but the relative
change is small. Also the change in the consistency of the learned covariate
effects is small.
3.3.5 Qualitative analysis
Finally, we give concrete examples of potential findings that the approaches
can uncover and demonstrate how analysis based on a single peak may lead to
a different outcome depending on the choice of the peak.
The intervention-driven changes of individual peaks from two lipids along
with the covariate effects inferred by Models 1 and 3 are shown in Figure 8.
In the case of the sphingomyelin SM(d18:1/22:0), there are strong covariate
effects inferred by Model 3 but many of these effects become weaker when
inferred based on multiple peaks by Model 1. On the contrary, Model 3 infers
weak covariate effects for the ceramide Cer(d18:1/17:0) but based on multiple
peaks and Model 1, one of the effects is actually among the top-5 % strongest
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effects across the observed lipidome. These examples underline the fact that
conclusions based on mass spectral data are highly sensitive to the choice of
peak, but the variance therein can be reduced by model-based integration of
data from multiple associated peaks.
4 Conclusion
We have empirically demonstrated that a model-based integration of multiple
peaks can lead to an improved accuracy in the inference of covariate effects,
and introduced a novel method for this task. While the sample-size is always
restricted by external constraints such as the experiment budget or
the availability of suitable patients, the inference based on multiple peaks gives
a shortcut to extracting more information from the limited set of samples,
thereby directly addressing the “small n, large p” problem. However, some
types of systematic measurement error, such as some batch effects, escape this
treatment and can only be reduced by introducing independent replicates.
In this work, we have shown that additional peaks are especially useful when
the signal-to-noise ratio is low and the differences between sample groups are
small.
Mass spectral data are noisy to the extent that analysis of small
sample-size data sets based on individual spectral peaks is unreliable.
The result of this work indicates that additional peaks are useful to
the analysis by increasing the accuracy of the inferred covariate effects and by
reducing the variance in the estimates. Moreover, the result highlights the risk
of relying on a single peak in the comparative analysis of profiles and
especially in biomarker discovery. As demonstrated, the inferred covariate
effects may change drastically depending on the peak used, when relying on
a single peak in the analysis.
We suggest that all the detected peaks that can be associated with
a compound should be taken into account in the comparative analysis. This is
possible through the two-step generative modeling approach presented in this
work: (1) the identification of peaks that can be associated with one
compound by clustering the peaks based on their shape similarity and
(2) the inference of covariate effects on the clusters, each representing one
compound.
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1Figure 8: Example clusters of peaks from the lipidomic gene silencing data
with differences in the covariate effects inferred based on a single peak and
multiple peaks. There is noticeable variation between peaks associated with
one compound. The choice of the representative peak thus affects the inferred
covariate effects. The heat maps show changes in the lipid concentrations driven
by the gene silencing interventions (columns). Covariate effects inferred by
Models 3 and 1 using a single peak and all peaks, respectively, are shown
on the two bottom rows of each heat map. The log2 fold changes of each
peak associated with the compound are shown on the top rows. Changes that
by the magnitude fall to the top-5 % across the entire observed lipidome are
highlighted by the symbol ”T.“ Top (a): The sphingomyelin SM(d18:1-22:0)
with three peaks. Many strong changes for SM(d18:1-22:0) become weaker
when they are inferred based on all three peaks. Bottom (b): The ceramide
Cer(d18:1-17:0) with six peaks. The effect of the SCAP silencing for
Cer(d18:1-17:0) at 72 hours becomes strong when it is inferred based on all
six peaks.
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The calculations presented in the work were performed using computer
resources within the Aalto University School of Science ”Science-IT” project.
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